This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Victor Grifols Selected As "Business Leader Of The Year 2011" By The Spain - U.S. Chamber Of Commerce





 

BARCELONA, Spain, Dec. 6, 2011 /PRNewswire/ -- Victor Grifols Roura, president and managing director of Grifols, has been selected as the "Business Leader of the Year 2011" by the Spain – U.S. Chamber of Commerce, the premier forum fostering commercial, economic and industrial relations between Spain and the United States. This award, given annually, recognizes the professional career of business leaders who stand out in their industries, as well as their contribution to the globalization of the economy. In the case of Victor Grifols, his leadership as sales manager of Grifols since 1979, and as president and managing director since 1987 has driven the transition of Grifols and allowed it to grow from a family company to the third largest producer of plasma protein therapies worldwide.

(Logo:  http://photos.prnewswire.com/prnh/20110304/PH59473LOGO )

The award will be presented by Angeles Gonzalez Sinde, Minister of Cultural Affairs of the Government of Spain during the gala dinner that will take place on December 6th, 2011 at the Hotel Pierre in New York, and attendees will include notable political and business figures from both Spain and the United States.



Victor Grifols Roura studied Business Science at the University of Barcelona and joined Grifols in 1973. A man of great strategic and commercial vision, as the Commercial Director he was the architect of the restoration of Grifols' sales network in Spain. Additionally, as managing director, he was responsible for the in-depth reorganization of the company that allowed it to establish the basis for the multinational group that Grifols is today.

For Victor Grifols, international expansion has always been and continues to be essential to ensure the growth of his organization. In 1988 he opened the company's first international subsidiary in Portugal, inaugurating the process of progressive expansion of Grifols in other markets, whose first objective was Latin America, though entrance into the United States market was always the long-term goal.

During the 1990's the international expansion of the group took off, and one of the decisive factors of this was the acquiring of two Food & Drug Administration licenses in 1995: the Establishment License for the production plant in Parets del Valles ( Barcelona, Spain), and the Product License for its product, Albumin.

In 1998, Miami was designated as the site for the first American subsidiary of Grifols, with Central America and the Caribbean as its principal areas of influence, followed by Argentina and Chile in 1991. The disappearance of the Soviet Bloc in 1992 created the opportunity for a new subsidiary in the Czech Republic, and the following year, Mexico was chosen as the next country for expansion.

In 1997, European expansion began through acquisitions. The purchase of subsidiaries of Alpha Therapeutic Corporation in the United Kingdom, Germany and Italy permitted a rapid penetration into those markets and generated enough confidence for the company to leap to the United States, a world leader in the blood derivatives sector. In the years 2002 and 2003, two acquisitions planted the roots of Grifols in the US: the purchase of SeraCare, that ensured the supply of raw materials through the expansion of its plasma acquisition centers, and a large part of the assets of Alpha Therapeutic Corporation, including its plasma division and protein purification plants for the in Los Angeles.

Presently, Grifols maintains a strong presence on the North American market and the internationalization of the group has translated into a global commercial presence including more than 90 countries with direct subsidiaries in 24.

Stock quotes in this article: GRF, GRFS 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs